kariusdx.comKarius Non-Invasive Pathogen Blood Test - Karius

News Join Our Team Access Results Karius Test ® Diagnostic Applications › Pneumonia Febrile Neutropenia Invasive Fungal Infections Endocarditis FUO Antimicrobial Resistance Detection Pathogen List Test Process Test Reporting Access Results Mobile App Order Test Clinical Evidence Clinical Data Analytical and Clinical Validation PICKUP Study Resources Media Events News and Press Releases FAQs About Our Team Biopharma Partnering Join Our Team Contact Us Order Test Karius Raises $100M in Series C Funding Round to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis Karius Test ® Diagnostic Applications › Pneumonia Febrile Neutropenia Invasive Fungal Infections Endocarditis FUO Antimicrobial Resistance Detection Pathogen List Test Process Test Reporting Access Results Mobile App Order Test Clinical Evidence Clinical Data Analytical and Clinical Validation PICKUP Study Resources Media Events News and Press Releases FAQs About Our Team Biopharma Partnering Join Our Team Contact Us GET THE COMPLETE DIAGNOSTIC PICTURE GET THE COMPLETE DIAGNOSTIC PICTURE Karius is a life sciences company focused on saving lives. We are committed to advancing diagnostic science and technology to optimize treatment for infectious disease. The Karius Test® is a liquid biopsy for infectious diseases. From a single blood sample, the Karius Test can non-invasively and rapidly detect over 1,000 pathogens associated with both deep-seated and bloodstream infections. The Karius Test may help clinicians avoid many invasive, low-yield, and sequential diagnostic tests that can delay treatment for vulnerable hospitalized patients. We use genomics and AI to advance infectious disease diagnostics. Microbial Cell-Free DNA Karius provides unique genomic insights by detecting microbial cell–free DNA (mcfDNA) circulating in the bloodstream from more than 1000 pathogens that cause infections. AI Technology Advanced machine learning algorithms allow analysis of complex genomic data in real time. Our proprietary reference genome databases are constantly refined as more data becomes available. PICKUP Study Pneumonia in the ImmunoCompromised: Use of the Karius Test for the Detection of Undiagnosed Pathogens New to Karius Order the Karius Test Existing Customer Access Results Awards Stay up-to-date with Karius Sign up today to receive notification of future real-world cases of the Karius Test being used by physicians and upcoming events. Contact Us Karius Test ® Clinical Evidence ResourcesAccess Results Careers Contact Us FAQs The Karius Test ® was developed and its performance characteristics determined by Karius. This test has not been cleared or approved by the FDA, nor is it required to be. The Karius laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ’88) and is accredited by the College of American Pathologists (CAP) to perform high-complexity clinical laboratory testing. 975 Island Drive Redwood City, CA 94065 help@kariusdx.com +1 (866) 452-7487 © 2024 Karius, Inc. Terms & Conditions Privacy Policy Licensure Code of Conduct CLIA #05D2121236 | CAP...